ID   RBL2_RAT                Reviewed;        1135 AA.
AC   O55081;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1998, sequence version 1.
DT   24-JUL-2024, entry version 161.
DE   RecName: Full=Retinoblastoma-like protein 2;
DE   AltName: Full=130 kDa retinoblastoma-associated protein;
DE            Short=p130;
DE   AltName: Full=PPAR-alpha-interacting complex protein 128;
DE            Short=PRIC128;
DE   AltName: Full=Retinoblastoma-related protein 2;
DE            Short=RBR-2;
DE   AltName: Full=pRb2;
GN   Name=Rbl2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Spleen;
RX   PubMed=9247086; DOI=10.1016/s0925-4439(97)00037-9;
RA   Sawada Y., Nomura H., Endo Y., Umeki K., Fujita T., Ohtaki S., Fujinaga K.;
RT   "Cloning and characterization of the rat p130, a member of the
RT   retinoblastoma gene family.";
RL   Biochim. Biophys. Acta 1361:20-27(1997).
RN   [2]
RP   PROTEIN SEQUENCE OF 276-288 AND 829-838, AND SUBUNIT.
RC   TISSUE=Liver;
RX   PubMed=12189208; DOI=10.1073/pnas.182426699;
RA   Surapureddi S., Yu S., Bu H., Hashimoto T., Yeldandi A.V., Kashireddy P.,
RA   Cherkaoui-Malki M., Qi C., Zhu Y.-J., Rao M.S., Reddy J.K.;
RT   "Identification of a transcriptionally active peroxisome proliferator-
RT   activated receptor alpha-interacting cofactor complex in rat liver and
RT   characterization of PRIC285 as a coactivator.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:11836-11841(2002).
RN   [3]
RP   INTERACTION WITH RBBP9.
RX   PubMed=9697699; DOI=10.1038/1258;
RA   Woitach J.T., Zhang M., Niu C.-H., Thorgeirsson S.S.;
RT   "A retinoblastoma-binding protein that affects cell-cycle control and
RT   confers transforming ability.";
RL   Nat. Genet. 19:371-374(1998).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-636; THR-639; SER-946;
RP   SER-1064 AND SER-1108, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Key regulator of entry into cell division. Directly involved
CC       in heterochromatin formation by maintaining overall chromatin structure
CC       and, in particular, that of constitutive heterochromatin by stabilizing
CC       histone methylation. Recruits and targets histone methyltransferases
CC       KMT5B and KMT5C, leading to epigenetic transcriptional repression.
CC       Controls histone H4 'Lys-20' trimethylation. Probably acts as a
CC       transcription repressor by recruiting chromatin-modifying enzymes to
CC       promoters. Potent inhibitor of E2F-mediated trans-activation,
CC       associates preferentially with E2F5. Binds to cyclins A and E. Binds to
CC       and may be involved in the transforming capacity of the adenovirus E1A
CC       protein. May act as a tumor suppressor (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with AATF, KMT5B and KMT5C. Component of the DREAM
CC       complex (also named LINC complex) at least composed of E2F4, E2F5,
CC       LIN9, LIN37, LIN52, LIN54, MYBL1, MYBL2, RBL1, RBL2, RBBP4, TFDP1 and
CC       TFDP2. The complex exists in quiescent cells where it represses cell
CC       cycle-dependent genes. It dissociates in S phase when LIN9, LIN37,
CC       LIN52 and LIN54 form a subcomplex that binds to MYBL2. Interacts with
CC       USP4 (By similarity). Part of the peroxisome proliferator activated
CC       receptor alpha (PPAR-alpha) interacting complex (PRIC). Interacts with
CC       RINT1 (By similarity). Interacts with PML (By similarity). Interacts
CC       with RBBP9 (PubMed:9697699). Interacts with CD53 (By similarity).
CC       {ECO:0000250|UniProtKB:P67775, ECO:0000250|UniProtKB:Q08999,
CC       ECO:0000269|PubMed:9697699}.
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- PTM: During G0 and early G1 phase of the cell cycle, phosphorylated on
CC       Ser-636 and on 5 sites within the domain B. Phosphorylation on Ser-669
CC       in G1 leads to its ubiquitin-dependent proteolysis (By similarity).
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the retinoblastoma protein (RB) family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D55627; BAA24196.1; -; mRNA.
DR   RefSeq; NP_112356.1; NM_031094.1.
DR   AlphaFoldDB; O55081; -.
DR   SMR; O55081; -.
DR   BioGRID; 249630; 5.
DR   IntAct; O55081; 1.
DR   STRING; 10116.ENSRNOP00000017361; -.
DR   iPTMnet; O55081; -.
DR   PhosphoSitePlus; O55081; -.
DR   PaxDb; 10116-ENSRNOP00000017361; -.
DR   GeneID; 81758; -.
DR   KEGG; rno:81758; -.
DR   AGR; RGD:3541; -.
DR   CTD; 5934; -.
DR   RGD; 3541; Rbl2.
DR   eggNOG; KOG1010; Eukaryota.
DR   InParanoid; O55081; -.
DR   OrthoDB; 519973at2759; -.
DR   PhylomeDB; O55081; -.
DR   Reactome; R-RNO-1538133; G0 and Early G1.
DR   Reactome; R-RNO-69231; Cyclin D associated events in G1.
DR   PRO; PR:O55081; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0000785; C:chromatin; IDA:RGD.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0005667; C:transcription regulator complex; ISO:RGD.
DR   GO; GO:1990841; F:promoter-specific chromatin binding; ISO:RGD.
DR   GO; GO:0000977; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; IBA:GO_Central.
DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.
DR   GO; GO:0006325; P:chromatin organization; IEA:UniProtKB-KW.
DR   GO; GO:2000134; P:negative regulation of G1/S transition of mitotic cell cycle; IBA:GO_Central.
DR   GO; GO:0010629; P:negative regulation of gene expression; ISO:RGD.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IEA:InterPro.
DR   CDD; cd20606; CYCLIN_RBL2; 1.
DR   CDD; cd00043; CYCLIN_SF; 1.
DR   Gene3D; 1.10.472.140; -; 1.
DR   Gene3D; 1.10.472.10; Cyclin-like; 3.
DR   InterPro; IPR013763; Cyclin-like_dom.
DR   InterPro; IPR036915; Cyclin-like_sf.
DR   InterPro; IPR002720; RB_A.
DR   InterPro; IPR002719; RB_B.
DR   InterPro; IPR015030; RB_C.
DR   InterPro; IPR028309; RB_fam.
DR   InterPro; IPR024599; RB_N.
DR   PANTHER; PTHR13742; RETINOBLASTOMA-ASSOCIATED PROTEIN RB -RELATED; 1.
DR   PANTHER; PTHR13742:SF8; RETINOBLASTOMA-LIKE PROTEIN 2; 1.
DR   Pfam; PF11934; DUF3452; 1.
DR   Pfam; PF01858; RB_A; 1.
DR   Pfam; PF01857; RB_B; 1.
DR   SMART; SM00385; CYCLIN; 2.
DR   SMART; SM01367; DUF3452; 1.
DR   SMART; SM01368; RB_A; 1.
DR   SMART; SM01369; Rb_C; 1.
DR   SUPFAM; SSF47954; Cyclin-like; 3.
PE   1: Evidence at protein level;
KW   Cell cycle; Chromatin regulator; Direct protein sequencing; DNA-binding;
KW   Glycoprotein; Nucleus; Phosphoprotein; Reference proteome; Repressor;
KW   Transcription; Transcription regulation; Tumor suppressor.
FT   CHAIN           1..1135
FT                   /note="Retinoblastoma-like protein 2"
FT                   /id="PRO_0000167843"
FT   REGION          1..43
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          414..1021
FT                   /note="Pocket; binds E1A"
FT   REGION          414..613
FT                   /note="Domain A"
FT   REGION          614..824
FT                   /note="Spacer"
FT   REGION          649..698
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          806..825
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          825..1021
FT                   /note="Domain B"
FT   REGION          932..995
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        654..691
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        939..971
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         410
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q08999"
FT   MOD_RES         414
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q64700"
FT   MOD_RES         636
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         639
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         659
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q08999"
FT   MOD_RES         669
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q08999"
FT   MOD_RES         684
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q08999"
FT   MOD_RES         942
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q64700"
FT   MOD_RES         946
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         960
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q08999"
FT   MOD_RES         965
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q08999"
FT   MOD_RES         967
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q08999"
FT   MOD_RES         968
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q08999"
FT   MOD_RES         975
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q08999"
FT   MOD_RES         976
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q08999"
FT   MOD_RES         980
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q08999"
FT   MOD_RES         1031
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q08999"
FT   MOD_RES         1064
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1076
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q08999"
FT   MOD_RES         1108
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   CARBOHYD        417
FT                   /note="O-linked (GlcNAc) serine"
FT                   /evidence="ECO:0000250|UniProtKB:Q08999"
SQ   SEQUENCE   1135 AA;  127818 MW;  6C42A87E163B4298 CRC64;
     MASGGNQSSP PPPAAAASSE EEEEDGDTAD RAQPAGSPSH QIQQRFEELC SRLNMDEAAR
     AEAWSSYRSM SESYTLEGND LHWLACALYV ACRKSVPTVS KGTAEGNYVS LTRILRCSEQ
     SLIEFFNKMK KWEDMANLPP HFRERTERLE RNFTVSAVIF KKYEPIFQDI FKYPQEEQPR
     QQRGRKQRRQ PCTTSEIFHF CWVLFIYAKG NFPMISDDLV NSYHLLLCAL DLVYGNALQC
     SNRKELVNPN FKGVSEDGHP RDSHPSSDPP CVIEKLCSLH DGLVLEAKGI KQHFWKPYIR
     KLFEKKLLRG KEENLTGFLE PGNFAESFKA VNKAYEEYVL ATGSLDERIF LGEDAEEEVG
     TFSRCVSAAS GTESAERTQM RDILQQHLDK SKTLRVCNPL TGVRYVQENS PCVTPVSTAT
     HSLNRLHTML AGLRNAPSEK LEQILRSCSR DPTRAIADRL REMYEIYSQH FQPDENVSNC
     AKEMANKHFR FAEMLYYKVL ESVIEQEQKR LGDMDLSGVL EQDAFHKSLL ACCLEVVAFS
     YKPPGNFPFI AEIFDVPHYH FYKVIEVFIR AEDGLCREVV KHLNQIEEQI LDHLAWKTKS
     PLWDRIRDNE NRVPTCEEVT PPHNLERTDE IYIAGSPLTP RRVGEVRTDA GGLGRSVTSP
     TTLYDRYSSP TVSTTRRRLF ESDSPSEGST AGRIPPQPLV NAVPVQNVSG ETVSVTPVPG
     QTLVTMATAT VTANNGQTVT IPVQGIANEN GGITFFPVQV NVGGQAQAVT GSIQPLSAQA
     LAGSLSSQQV TGTTLQVPGP VAIQQISPGG QQQNQGQPLT SSSIRPRKTS SLSLFFRKVY
     YLAGVRLRDL CTKLDISDEL RKKIWTCFEF SIVQCPELMM DRHLDQLLMC AIYVMAKVTK
     EDKSFQNIMR CYRTQPQARS QVYRSVLIKG KRRNSGSCEN RSHQNSPTEL NTDRASRDSS
     PVMRSNSTLP VPQPSSAPPT PTRLTGANSD IEEEERGDLI QFYNNIYRKQ IQTFAMKYSQ
     ANSQMDTPPL SPYPFVRTGS PRRVQLSQSH PIYISPHKNE AMLSPREKIF YYFSNSPSKR
     LREINSMIRT GETPTKKRGI LLDDGSESPA KRICPENHSA LLRRLQDVAN DRGSH
//
